ATG13 blocking peptide product blog
Tags: Blocking Peptide; ATG13; ATG13 blocking peptide;
The ATG13 atg13 (Catalog #MBS9228484) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The ATG13 atg13 product has the following accession number(s) (GI #20140441) (NCBI Accession #O75143.1) (Uniprot Accession #O75143). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Autophagy factor required for autophagosome formation and mitophagy. Target of the TOR kinase signaling pathway that regulates autophagy through the control of the phosphorylation status of ATG13 and ULK1, and the regulation of the ATG13-ULK1- RB1CC1 complex. Through its regulation of ULK1 activity, plays a role in the regulation of the kinase activity of mTORC1 and cell proliferation.
Cellular Location: Cytoplasm, cytosol. Preautophagosomal structure. Note: Under starvation conditions, is localized to puncate structures primarily representing the isolation membrane; the isolation membrane sequesters a portion of the cytoplasm resulting in autophagosome formation. The following patways have been known to be associated with this gene. Atrophy, Breast Neoplasms, Cell Transformation, Neoplastic, Disease Models, Animal, Embryo Loss, Hypertrophy, Kidney Diseases, Mental Disorders, Necrosis, Nervous System Diseases are some of the diseases may be linked to ATG13 Antibody (N-term) Blocking Peptide. Blood, Brain, Eye, Heart, Kidney, Liver, Lung, Lymph Node, Muscle, Vascular tissues are correlated with this protein.